Literature DB >> 35209034

Synthesis and Antimicrobial, Anticancer and Anti-Oxidant Activities of Novel 2,3-Dihydropyrido[2,3-d]pyrimidine-4-one and Pyrrolo[2,1-b][1,3]benzothiazole Derivatives via Microwave-Assisted Synthesis.

Aamal A Al-Mutairi1, Hend N Hafez2, Abdel-Rhaman B A El-Gazzar2, Marwa Y A Mohamed3.   

Abstract

In our attempt towards the synthesis and development of effective antimicrobial, anticancer and antioxidant agents, a novel series of 2,3-dihydropyrido[2,3-d]pyrimidin-4-one 7a-e and pyrrolo[2,1-b][1,3]benzothiazoles 9a-e were synthesized. The synthesis of 2-(1,3-benzo thiazol-2-yl)-3-(aryl)prop-2-enenitrile (5a-e) as the key intermediate was accomplished by a microwave efficient method. Via a new variety oriented synthetic microwave pathway, these highly functionalized building blocks allowed access to numerous fused heteroaromatic such as 7-amino-6-(1,3-benzo thiazol-2-yl)-5-(aryl)-2-thioxo-2,3dihydropyrido [2,3-d]pyrimidin-4(1H)-one 7a-e and 1-amino-2-(aryl)pyrrolo[2,1-b][1,3]benzothiazole-3-carbonitrile derivatives 9a-e in order to study their antimicrobial and anticancer activity. The present investigation offers effective and rapid new procedures for the synthesis of the newly polycondensed heterocyclic ring systems. All the newly synthesized compounds were evaluated for antimicrobial, anticancer and antioxidant activity. Compounds 7a,d, and 9a,d showed higher antimicrobial activity than cefotaxime and fluconazole while the remaining compounds exhibited good to moderate activity against bacteria and fungi. An anticancer evaluation of the newly synthesized compounds against the three tumor cell lines (lung cell NCI-H460, liver cancer HepG2 and colon cancer HCT-116) exhibited that compounds 7a, d, and 9a,d have higher cytotoxicity against the three human cell lines compared to doxorubicin as a reference drug. These compounds also exhibited higher antioxidant activity and a great ability to protect DNA from damage induced by bleomycin.

Entities:  

Keywords:  anticancer; antimicrobial; antioxidant activity; arylidenes; microwave; pyrido[2,3-d]pyrimidine; pyrrolo[2,1-b][1,3]benzothiazole

Mesh:

Substances:

Year:  2022        PMID: 35209034      PMCID: PMC8880104          DOI: 10.3390/molecules27041246

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  28 in total

1.  A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity.

Authors:  Stephen Michael Rajesh; Raju Suresh Kumar; Lawzer Arun Libertsen; Subbu Perumal; Perumal Yogeeswari; Dharmarajan Sriram
Journal:  Bioorg Med Chem Lett       Date:  2011-03-17       Impact factor: 2.823

2.  Synthesis and antiproliferative activity of a series of novel 6-substituted pyrido[3,2-d]pyrimidines as potential nonclassical lipophilic antifolates targeting dihydrofolate reductase.

Authors:  Meng Wang; Jiajia Yang; Mengmeng Yuan; Liangmin Xue; Hao Li; Chao Tian; Xiaowei Wang; Junyi Liu; Zhili Zhang
Journal:  Eur J Med Chem       Date:  2017-01-25       Impact factor: 6.514

3.  Development of β-carboline-benzothiazole hybrids via carboxamide formation as cytotoxic agents: DNA intercalative topoisomerase IIα inhibition and apoptosis induction.

Authors:  Ramya Tokala; Surbhi Mahajan; Gaddam Kiranmai; Dilep Kumar Sigalapalli; Sravani Sana; Stephy Elza John; Narayana Nagesh; Nagula Shankaraiah
Journal:  Bioorg Chem       Date:  2020-11-18       Impact factor: 5.275

4.  Optimization of Benzothiazole and Thiazole Hydrazones as Inhibitors of Schistosome BCL-2.

Authors:  William Nguyen; Erinna F Lee; Marco Evangelista; Mihwa Lee; Tiffany J Harris; Peter M Colman; Nicholas A Smith; Luke B Williams; Kate E Jarman; Kym N Lowes; Cécile Haeberli; Jennifer Keiser; Brian J Smith; W Douglas Fairlie; Brad E Sleebs
Journal:  ACS Infect Dis       Date:  2021-02-01       Impact factor: 5.084

5.  Synthesis of 2,4-diamino-6-(thioarylmethyl)pyrido[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.

Authors:  A Gangjee; O Adair; S F Queener
Journal:  Bioorg Med Chem       Date:  2001-11       Impact factor: 3.641

6.  Development of fluorinated and methoxylated benzothiazole derivatives as highly potent and selective cannabinoid CB2 receptor ligands.

Authors:  Mayar W Aly; Friedrich-Alexander Ludwig; Winnie Deuther-Conrad; Peter Brust; Ashraf H Abadi; Rareş-Petru Moldovan; Noha A Osman
Journal:  Bioorg Chem       Date:  2021-07-21       Impact factor: 5.275

7.  Developing a scaffold for urease inhibition based on benzothiazoles: Synthesis, docking analysis, and therapeutic potential.

Authors:  Musa Özil; Özge Tuzcuoğlu; Mustafa Emirik; Nimet Baltaş
Journal:  Arch Pharm (Weinheim)       Date:  2021-09-21       Impact factor: 3.751

8.  New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study.

Authors:  Mehdi Adib; Fariba Peytam; Mahmoud Rahmanian-Jazi; Shabnam Mahernia; Hamid Reza Bijanzadeh; Mehdi Jahani; Maryam Mohammadi-Khanaposhtani; Somaye Imanparast; Mohammad Ali Faramarzi; Mohammad Mahdavi; Bagher Larijani
Journal:  Eur J Med Chem       Date:  2018-05-29       Impact factor: 6.514

9.  Synthesis of new pyrimidine-fused derivatives as potent and selective antidiabetic α-glucosidase inhibitors.

Authors:  Farhad Panahi; Reza Yousefi; Mohammad Hossein Mehraban; Ali Khalafi-Nezhad
Journal:  Carbohydr Res       Date:  2013-08-06       Impact factor: 2.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.